Compare $CLPT vs $TMCI | Chartloom

Compare

$CLPT vs $TMCI

Clearpoint Neuro Inc · Treace Medical Concepts, Inc

CLPT

Clearpoint Neuro Inc

TMCI

Treace Medical Concepts, Inc

Compare $CLPT vs $TMCI

Comparing Clearpoint Neuro Inc and Treace Medical Concepts, Inc

CLPTClearpoint Neuro Inc

TMCITreace Medical Concepts, Inc

CLPTClearpoint Neuro Inc

Market cap

$314M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.82x

Rev growth (TTM)

25.9%

YTD performance

-25.3%

52W performance

-64.6%

FCF yield

-10.0%

TMCITreace Medical Concepts, Inc

Market cap

$256M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.17x

Rev growth (TTM)

-4.0%

YTD performance

58.0%

52W performance

-35.9%

FCF yield

-9.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLPT

TMCI

Detailed metrics comparison

CLPT

Clearpoint Neuro Inc

TMCI

Treace Medical Concepts, Inc

Market Cap

CLPT$314M

TMCI$256M

Enterprise Value

CLPT$335M

TMCI$303M

Price

CLPT$10.48

TMCI$3.95

P/E Ratio

CLPTN/A

TMCIN/A

P/S Ratio

CLPT7.43x

TMCI1.25x

EV/Sales

CLPT7.93x

TMCI1.48x

EV/EBITDA

CLPT0.00x

TMCI0.00x

P/B Ratio

CLPT30.84x

TMCI4.21x

P/FCF Ratio

CLPTN/A

TMCIN/A

EV/FCF

CLPT-10.71x

TMCI-12.09x

PEG Ratio

CLPTN/A

TMCIN/A

Forward P/E (NTM)

CLPTN/A

TMCIN/A

Forward P/S (NTM)

CLPT5.82x

TMCI1.17x

Revenue (TTM)

CLPT$42M

TMCI$205M

Revenue Growth (YoY)

CLPT25.9%

TMCI-4.0%

Forward Rev Growth

CLPT15.4%

TMCI6.8%

Gross Margin (TTM)

CLPT62.6%

TMCI79.5%

Operating Margin (TTM)

CLPT0.0%

TMCI0.0%

EBITDA Margin (TTM)

CLPT-69.3%

TMCI-22.1%

Net Margin (TTM)

CLPT-81.8%

TMCI-29.0%

FCF Margin (TTM)

CLPT-74.0%

TMCI-12.2%

Net Income (TTM)

CLPT$-35M

TMCI$-60M

FCF (TTM)

CLPT$-31M

TMCI$-25M

EPS (TTM)

CLPT-$1.15

TMCI-$0.91

ROE (TTM)

CLPT-18809.0%

TMCI-7406.0%

ROA (TTM)

CLPT-4087.0%

TMCI-3164.0%

ROIC (TTM)

CLPT-5494.0%

TMCI-4349.0%

Cash

CLPT$29M

TMCI$13M

Debt

CLPT$50M

TMCI$59M

Net Cash/Debt

CLPT$-21M

TMCI$-47M

Current Ratio (TTM)

CLPT4.74x

TMCI2.90x

Quick Ratio (TTM)

CLPT3.75x

TMCI1.79x

Debt/Equity (TTM)

CLPT4.66x

TMCI0.87x

Debt/Assets (TTM)

CLPT0.0%

TMCI0.0%

Interest Coverage (TTM)

CLPTN/A

TMCIN/A

Net Debt/EBITDA (TTM)

CLPT0.00x

TMCI0.00x

Beta

CLPT1.31

TMCI1.57

52W Performance

CLPT-64.6%

TMCI-35.9%

YTD Performance

CLPT-25.3%

TMCI58.0%

% from 52W High

CLPT-65.2%

TMCI-44.2%

% from 52W Low

CLPT26.7%

TMCI237.6%

Asset Turnover (TTM)

CLPT0.50x

TMCI1.09x

FCF Yield (TTM)

CLPT-10.0%

TMCI-9.8%

Earnings Yield (TTM)

CLPT-11.0%

TMCI-23.2%

Dividend Yield (TTM)

CLPTN/A

TMCIN/A

Rule of 40

CLPT-48.2

TMCI-16.1

EV/GP/RG

CLPT0.46

TMCI0.24

Ticker research

View CLPT research View TMCI research

Metric	CLPT Clearpoint Neuro Inc	TMCI Treace Medical Concepts, Inc
Market & Valuation
Market Cap	$314M	$256M
Enterprise Value	$335M	$303M
Price	$10.48	$3.95
P/E Ratio	N/A	N/A
P/S Ratio	7.43x	1.25x
EV/Sales	7.93x	1.48x
EV/EBITDA	0.00x	0.00x
P/B Ratio	30.84x	4.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.71x	-12.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.82x	1.17x
Revenue & Growth
Revenue (TTM)	$42M	$205M
Revenue Growth (YoY)	25.9%	-4.0%
Forward Rev Growth	15.4%	6.8%
Profitability
Gross Margin (TTM)	62.6%	79.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-69.3%	-22.1%
Net Margin (TTM)	-81.8%	-29.0%
FCF Margin (TTM)	-74.0%	-12.2%
Net Income (TTM)	$-35M	$-60M
FCF (TTM)	$-31M	$-25M
EPS (TTM)	-$1.15	-$0.91
ROE (TTM)	-18809.0%	-7406.0%
ROA (TTM)	-4087.0%	-3164.0%
ROIC (TTM)	-5494.0%	-4349.0%
Financial Health
Cash	$29M	$13M
Debt	$50M	$59M
Net Cash/Debt	$-21M	$-47M
Current Ratio (TTM)	4.74x	2.90x
Quick Ratio (TTM)	3.75x	1.79x
Debt/Equity (TTM)	4.66x	0.87x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	1.57
52W Performance	-64.6%	-35.9%
YTD Performance	-25.3%	58.0%
% from 52W High	-65.2%	-44.2%
% from 52W Low	26.7%	237.6%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	1.09x
FCF Yield (TTM)	-10.0%	-9.8%
Earnings Yield (TTM)	-11.0%	-23.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-48.2	-16.1
EV/GP/RG	0.46	0.24
Ticker research	View CLPT research	View TMCI research

Valuation

P/S Ratio

TMCI

1.25x

CLPT

7.43x

EV/FCF

TMCI

-12.09x

CLPT

-10.71x

Growth & revenue

Revenue Growth TTM

CLPT

25.9%

TMCI

-4.0%

Forward Revenue Growth

CLPT

15.4%

TMCI

6.8%

Profitability & performance

Gross Margin

TMCI

79.5%

CLPT

62.6%

ROE

TMCI

-7406.0%

CLPT

-18809.0%

FCF Yield %

TMCI

-9.8%

CLPT

-10.0%

52-Week Performance

TMCI

-35.9%

CLPT

-64.6%

Detailed metrics comparison

CLPT

Clearpoint Neuro Inc

TMCI

Treace Medical Concepts, Inc

Market Cap

CLPT$314M

TMCI$256M

Enterprise Value

CLPT$335M

TMCI$303M

Price

CLPT$10.48

TMCI$3.95

P/E Ratio

CLPTN/A

TMCIN/A

P/S Ratio

CLPT7.43x

TMCI1.25x

EV/Sales

CLPT7.93x

TMCI1.48x

EV/EBITDA

CLPT0.00x

TMCI0.00x

P/B Ratio

CLPT30.84x

TMCI4.21x

P/FCF Ratio

CLPTN/A

TMCIN/A

EV/FCF

CLPT-10.71x

TMCI-12.09x

PEG Ratio

CLPTN/A

TMCIN/A

Forward P/E (NTM)

CLPTN/A

TMCIN/A

Forward P/S (NTM)

CLPT5.82x

TMCI1.17x

Revenue (TTM)

CLPT$42M

TMCI$205M

Revenue Growth (YoY)

CLPT25.9%

TMCI-4.0%

Forward Rev Growth

CLPT15.4%

TMCI6.8%

Gross Margin (TTM)

CLPT62.6%

TMCI79.5%

Operating Margin (TTM)

CLPT0.0%

TMCI0.0%

EBITDA Margin (TTM)

CLPT-69.3%

TMCI-22.1%

Net Margin (TTM)

CLPT-81.8%

TMCI-29.0%

FCF Margin (TTM)

CLPT-74.0%

TMCI-12.2%

Net Income (TTM)

CLPT$-35M

TMCI$-60M

FCF (TTM)

CLPT$-31M

TMCI$-25M

EPS (TTM)

CLPT-$1.15

TMCI-$0.91

ROE (TTM)

CLPT-18809.0%

TMCI-7406.0%

ROA (TTM)

CLPT-4087.0%

TMCI-3164.0%

ROIC (TTM)

CLPT-5494.0%

TMCI-4349.0%

Cash

CLPT$29M

TMCI$13M

Debt

CLPT$50M

TMCI$59M

Net Cash/Debt

CLPT$-21M

TMCI$-47M

Current Ratio (TTM)

CLPT4.74x

TMCI2.90x

Quick Ratio (TTM)

CLPT3.75x

TMCI1.79x

Debt/Equity (TTM)

CLPT4.66x

TMCI0.87x

Debt/Assets (TTM)

CLPT0.0%

TMCI0.0%

Interest Coverage (TTM)

CLPTN/A

TMCIN/A

Net Debt/EBITDA (TTM)

CLPT0.00x

TMCI0.00x

Beta

CLPT1.31

TMCI1.57

52W Performance

CLPT-64.6%

TMCI-35.9%

YTD Performance

CLPT-25.3%

TMCI58.0%

% from 52W High

CLPT-65.2%

TMCI-44.2%

% from 52W Low

CLPT26.7%

TMCI237.6%

Asset Turnover (TTM)

CLPT0.50x

TMCI1.09x

FCF Yield (TTM)

CLPT-10.0%

TMCI-9.8%

Earnings Yield (TTM)

CLPT-11.0%

TMCI-23.2%

Dividend Yield (TTM)

CLPTN/A

TMCIN/A

Rule of 40

CLPT-48.2

TMCI-16.1

EV/GP/RG

CLPT0.46

TMCI0.24

Ticker research

View CLPT research View TMCI research

Metric	CLPT Clearpoint Neuro Inc	TMCI Treace Medical Concepts, Inc
Market & Valuation
Market Cap	$314M	$256M
Enterprise Value	$335M	$303M
Price	$10.48	$3.95
P/E Ratio	N/A	N/A
P/S Ratio	7.43x	1.25x
EV/Sales	7.93x	1.48x
EV/EBITDA	0.00x	0.00x
P/B Ratio	30.84x	4.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.71x	-12.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.82x	1.17x
Revenue & Growth
Revenue (TTM)	$42M	$205M
Revenue Growth (YoY)	25.9%	-4.0%
Forward Rev Growth	15.4%	6.8%
Profitability
Gross Margin (TTM)	62.6%	79.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-69.3%	-22.1%
Net Margin (TTM)	-81.8%	-29.0%
FCF Margin (TTM)	-74.0%	-12.2%
Net Income (TTM)	$-35M	$-60M
FCF (TTM)	$-31M	$-25M
EPS (TTM)	-$1.15	-$0.91
ROE (TTM)	-18809.0%	-7406.0%
ROA (TTM)	-4087.0%	-3164.0%
ROIC (TTM)	-5494.0%	-4349.0%
Financial Health
Cash	$29M	$13M
Debt	$50M	$59M
Net Cash/Debt	$-21M	$-47M
Current Ratio (TTM)	4.74x	2.90x
Quick Ratio (TTM)	3.75x	1.79x
Debt/Equity (TTM)	4.66x	0.87x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	1.57
52W Performance	-64.6%	-35.9%
YTD Performance	-25.3%	58.0%
% from 52W High	-65.2%	-44.2%
% from 52W Low	26.7%	237.6%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	1.09x
FCF Yield (TTM)	-10.0%	-9.8%
Earnings Yield (TTM)	-11.0%	-23.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-48.2	-16.1
EV/GP/RG	0.46	0.24
Ticker research	View CLPT research	View TMCI research